Bose, J.S. and Gangan, V. and Jain, S.K. and Manna, S.K. (2009) Downregulation of Inflammatory Responses by Novel Caffeic Acid Ester Derivative by Inhibiting NF-kappa B. Journal of Clinical Immunology, 29 (1). pp. 90-98. ISSN 0271-9142

Text J Clin Immunol 29 p90.pdf Restricted to Repository staff only Download (410Kb) | Request a copy

Abstract

INTRODUCTION: Considering anti-tumorigenic activity of caffeic acid phenyl ester, synthesis of several esterified form of caffeic acid is a novel approach in designing for potent drugs. RESULTS: Our study demonstrates that esterified caffeic acid with methyl vanillate, termed as caffeic acid methyl vanillate ester (CAMVE), blocked inflammatory stimuli-induced inflammatory responses. It decreased amounts of iNOS, Cox-2, and ICAM1 by inhibiting NF-kappaB through inhibition of IKK activity, I kappaB alpha degradation, and p65 nuclear translocation. CONCLUSION: Overall, our data suggest that novel caffeic acid ester down-regulates inflammatory responses through inhibition of NF-kappaB and dependent several gene expressions, further suggesting its efficacy as a promising therapeutic agent.

Item Type:	Article
Depositing User:	Users 2 not found.
Date Deposited:	26 Aug 2015 09:54
Last Modified:	26 Aug 2015 09:54
URI:	http://cdfd.sciencecentral.in/id/eprint/388

Actions (login required)

View Item